| |
Bogi Andersen , M.D. -
Hyeon-Man Baek , Ph.D. -
Catherine Blake , M.S. -
John Butler , M.D. -
John Butler , M.D. -
Ralph Delfino , M.D., Ph.D. -
Mikhail Geyfman , B.S. -
Erin Goldblatt , Ph.D. -
Bingnan Gu , Ph.D. -
Gultekin Gulsen , Ph.D. -
Randall Holcombe , M.D. -
Randall Holcombe , M.D. -
Nola Hylton , Ph.D. -
Peter Kaiser , Ph.D. -
Peter Kaiser , Ph.D. -
Keon Wook Kang , Ph.D. -
Muqing Lin , M.S. -
J. Lawrence Marsh , -
Sean Merritt , B.S. -
Shiraz Mishra , M.B.B.S., Ph.D -
Orhan Nalcioglu , Ph.D. -
Orhan Nalcioglu , Ph.D. -
Edward Nelson , M.D. -
Edward Nelson , M.D. -
Susan Neuhausen , Ph.D. -
Ke Nie , M.S. -
Sora Park Tanjasiri , DrPH, MPH -
Sora Park Tanjasiri , DrPH, MPH -
Michael Samoszuk , M.D. -
Michael Samoszuk , M.D. -
Min-Ying (Lydia) Su , Ph.D. -
Min-Ying (Lydia) Su , Ph.D. -
Michelle Tabb , Ph.D. -
Heidi Theisen , Ph.D. -
Bruce Tromberg , Ph.D. -
Bruce Tromberg , Ph.D. -
Bruce Tromberg , Ph.D. -
Lan Truong , B.S. -
Connie Tsai , B.S. -
Suman Verma , Ph.D. -
Marian Waterman , Ph.D. -
Marian Waterman , Ph.D. -
Xiaoman Xu , B.S. -
Min Yang , M.D.,M.S. -
Kyoko Yokomori , Ph.D. -
Zhengquan Yu , Ph.D. -
Jiewen Zhu , Ph.D. -
Argyrios Ziogas , Ph.D. -
|
| Title[sort] |
Cycle |
Award[sort] |
| MRI Registration for Therapy Evaluation and Annual Screening |
2010 (Cycle 16) |
$76,000 |
| Investigator(s): Muqing Lin , M.S. |
16GB-0056 |
| The Role of Clim Proteins in Breast Cancer |
2010 (Cycle 16) |
$90,000 |
| Investigator(s): Suman Verma , Ph.D. |
16FB-0028 |
| Hec1 Inhibitor Synergizes With Taxol in Breast Cancer |
2010 (Cycle 16) |
$90,000 |
| Investigator(s): Erin Goldblatt , Ph.D. |
16FB-0026 |
| Inhibitors of Condensin I as Chemotherapy for Breast Cancer |
2009 (Cycle 15) |
$100,000 |
| Investigator(s): Kyoko Yokomori , Ph.D. |
15IB-0089 |
| Development of a Breast MRI Computer-Aided Diagnosis System |
2008 (Cycle 14) |
$76,000 |
| Investigator(s): Ke Nie , M.S. |
14GB-0148 |
| Role of Estrogen-modulated Protein AGR2 in Breast Cancer |
2008 (Cycle 14) |
$71,491 |
| Investigator(s): Mikhail Geyfman , B.S. |
14GB-0163 |
| Regulation of Breast Stem-Progenitor Cell Chromatin by Pygo2 |
2008 (Cycle 14) |
$135,000 |
| Investigator(s): Bingnan Gu , Ph.D. |
14FB-0129 |
| The Relationship of BRCA1 and HMGA2 in Breast Cancer |
2007 (Cycle 13) |
$36,704 |
| Investigator(s): Connie Tsai , B.S. |
13GB-0152 |
| Competition for ADA2 and 3 to Inhibit p53 in Breast Cancer |
2007 (Cycle 13) |
$21,574 |
| Investigator(s): Min Yang , M.D.,M.S. |
13GB-0154 |
| Combined Imaging Modalities for Breast Cancer |
2006 (Cycle 12) |
$148,772 |
| Investigator(s): Gultekin Gulsen , Ph.D. |
12IB-0095 |
| In Vivo MRS for Cancer Diagnosis and Treatment Monitoring |
2006 (Cycle 12) |
$90,000 |
| Investigator(s): Hyeon-Man Baek , Ph.D. |
12FB-0031 |
| Modulation of TGF-beta Signaling in Mammary Epithelial Cells |
2005 (Cycle 11) |
$73,723 |
| Investigator(s): Xiaoman Xu , B.S. |
11GB-0143 |
| A Role for p53 and Splicing Factor SAP145 in Breast Cancer |
2005 (Cycle 11) |
$76,000 |
| Investigator(s): Lan Truong , B.S. |
11GB-0104 |
| Inhibition of the BRCA2-RAD51 Interaction in Breast Cancer |
2005 (Cycle 11) |
$134,769 |
| Investigator(s): Jiewen Zhu , Ph.D. |
11FB-0117 |
| The Role of LMO4 in Breast Cancer |
2005 (Cycle 11) |
$135,000 |
| Investigator(s): Zhengquan Yu , Ph.D. |
11FB-0142 |
| Identification of BRCA1 Ubiquitylation Targets |
2005 (Cycle 11) |
$199,600 |
| Investigator(s): Peter Kaiser , Ph.D. |
11NB-0177 |
| Breast Cancer Functional Imaging with Optics and MRI |
2004 (Cycle 10) |
$500,000 |
| Investigator(s): Bruce Tromberg , Ph.D. |
10EB-0208 |
| Breast Cancer Functional Imaging with Optics and MRI |
2004 (Cycle 10) |
$500,000 |
| Investigator(s): John Butler , M.D. |
10EB-0208 |
| Breast Cancer Functional Imaging with Optics and MRI |
2004 (Cycle 10) |
$500,000 |
| Investigator(s): Nola Hylton , Ph.D. |
10EB-0208 |
| The IGF Pathway & Breast Cancer Risk in African Americans |
2003 (Cycle IX) |
$422,467 |
| Investigator(s): Susan Neuhausen , Ph.D. |
9PB-0142 |
| Pilot Studies of Breast Cancer Immunophototherapy |
2003 (Cycle IX) |
$99,834 |
| Investigator(s): Edward Nelson , M.D. |
9IB-0119 |
| Identification of BRCA1 Ubiquitylation Targets |
2003 (Cycle IX) |
$75,000 |
| Investigator(s): Peter Kaiser , Ph.D. |
9IB-0124 |
| Angiogenesis in Hyperplasia to In-Situ Breast Cancers |
2003 (Cycle IX) |
$250,000 |
| Investigator(s): Min-Ying (Lydia) Su , Ph.D. |
9WB-0020 |
| Combined Optical and MRI Imaging for Breast Cancer |
2003 (Cycle IX) |
$58,304 |
| Investigator(s): Sean Merritt , B.S. |
9GB-0085 |
| Mechanism of Estrogen Receptor Loss in Breast Cancer |
2003 (Cycle IX) |
$17,298 |
| Investigator(s): Keon Wook Kang , Ph.D. |
9FB-0135 |
| Clotting Breast Cancer |
2002 (Cycle VIII) |
$98,986 |
| Investigator(s): Michael Samoszuk , M.D. |
8IB-0009 |
| Using Scientific Text to Identify Breast Cancer Risk-Factors |
2002 (Cycle VIII) |
$29,136 |
| Investigator(s): Catherine Blake , M.S. |
8GB-0175 |
| A New Genetic Vaccine Therapy for Breast Cancer |
2001 (Cycle VII) |
$100,000 |
| Investigator(s): Edward Nelson , M.D. |
7WB-0114 |
| A Network-Based Intervention for Chamorros in Southern CA |
2001 (Cycle VII) |
$165,419 |
| Investigator(s): Sora Park Tanjasiri , DrPH, MPH |
7BB-1901S |
| Genetic and Environmental Modifiers of Breast Cancer Risk |
2000 (Cycle VI) |
$287,979 |
| Investigator(s): Argyrios Ziogas , Ph.D. |
6PB-0061 |
| Non-Invasive Optical Characterization of Breast Physiology |
2000 (Cycle VI) |
$499,915 |
| Investigator(s): Bruce Tromberg , Ph.D. |
6EB-0123 |
| Non-Invasive Optical Characterization of Breast Physiology |
2000 (Cycle VI) |
$499,915 |
| Investigator(s): John Butler , M.D. |
6EB-0123 |
| Wnt Signaling in Breast Cancer: Translational Studies |
2000 (Cycle VI) |
$328,129 |
| Investigator(s): Marian Waterman , Ph.D. |
6EB-0098 |
| Wnt Signaling in Breast Cancer: Translational Studies |
2000 (Cycle VI) |
$328,129 |
| Investigator(s): Randall Holcombe , M.D. |
6EB-0098 |
| Wnt Signaling in Breast Cancer: Translational Studies |
2000 (Cycle VI) |
$328,129 |
| Investigator(s): J. Lawrence Marsh , |
6EB-0098 |
| Thrombosis for Anti-angiogenic Therapy of Breast Cancer |
2000 (Cycle VI) |
$199,633 |
| Investigator(s): Min-Ying (Lydia) Su , Ph.D. |
6JB-0029 |
| SXR: A Novel Target for Breast Cancer Therapeutics |
1999 (Cycle V) |
$58,132 |
| Investigator(s): Michelle Tabb , Ph.D. |
5FB-0100 |
| A New Gene Regulation Factor, LMO-4, in Breast Cancer |
1999 (Cycle V) |
$54,823 |
| Investigator(s): Bogi Andersen , M.D. |
5JB-0119A |
| Samoans and Breast Cancer: Evaluating a Theory-Based Program |
1998 (Cycle IV) |
$168,946 |
| Investigator(s): Shiraz Mishra , M.B.B.S., Ph.D |
4BB-1401 |
| MRI Detection of Breast Cancer Blood Vessels |
1997 (Cycle III) |
$149,935 |
| Investigator(s): Orhan Nalcioglu , Ph.D. |
3IB-0028 |
| Regulation of Wnt: Clues for breast cancer pathognesis |
1997 (Cycle III) |
$13,849 |
| Investigator(s): Heidi Theisen , Ph.D. |
3FB-0090 |
| Breast Cancer Knowledge/Attitudes:So. Cal. Pacific Islanders |
1997 (Cycle III) |
$70,000 |
| Investigator(s): Sora Park Tanjasiri , DrPH, MPH |
3FB-0166 |
| Non-Invasive Optical Detection of Breast Cancer |
1996 (Cycle II) |
$50,000 |
| Investigator(s): Bruce Tromberg , Ph.D. |
2IB-0183 |
| Proper relocation of a tumor suppressor in Breast Cancer |
1996 (Cycle II) |
$50,000 |
| Investigator(s): Marian Waterman , Ph.D. |
2IB-0220 |
| Blocking Breast Cancer Progression with Radioactive Antibody |
1995 (Cycle I) |
$50,000 |
| Investigator(s): Michael Samoszuk , M.D. |
1IB-0219 |
| Investigation of Improved Drug Delivery in Breast Cancer |
1995 (Cycle I) |
$292,905 |
| Investigator(s): Orhan Nalcioglu , Ph.D. |
1RB-0160 |
| Susceptibility to Breast Cancer: Dietary and Other Factors |
1995 (Cycle I) |
$299,567 |
| Investigator(s): Ralph Delfino , M.D., Ph.D. |
1RB-0295 |
